Insulin Resistance – Types, Causes, Symptoms, Treatment

Last updated: February 8, 2026Reviewed date: February 8, 2026Reading time: 11 min read
Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Patient Mode

Understand this article easily

Switch between simple English and easy Bangla patient notes. This is for education and does not replace a doctor consultation.

Insulin resistance is identified as an impaired biologic response to insulin stimulation of target tissues, primarily the liver, muscle, and adipose tissue. Insulin resistance impairs glucose disposal, resulting in a compensatory increase in beta-cell insulin production and hyperinsulinemia. [rx][rx][rx]The metabolic consequences of insulin resistance can result...

For severe symptoms, danger signs, pregnancy, child illness, or sudden worsening, seek urgent medical care.

বাংলা রোগী নোট এখনো যোগ করা হয়নি। পোস্ট এডিটরে “RX Bangla Patient Mode” বক্স থেকে সহজ বাংলা সারাংশ যোগ করুন।

এই তথ্য শিক্ষা ও সচেতনতার জন্য। এটি ডাক্তারি পরীক্ষা, রোগ নির্ণয় বা প্রেসক্রিপশনের বিকল্প নয়।

Article Summary

Insulin resistance is identified as an impaired biologic response to insulin stimulation of target tissues, primarily the liver, muscle, and adipose tissue. Insulin resistance impairs glucose disposal, resulting in a compensatory increase in beta-cell insulin production and hyperinsulinemia. [rx][rx][rx]The metabolic consequences of insulin resistance can result in hyperglycemia, hypertension, dyslipidemia, visceral adiposity, hyperuricemia, elevated inflammatory markers, endothelial dysfunction, and a prothrombic state. Progression of insulin resistance...

Key Takeaways

  • This article explains Causes of Insulin Resistance in simple medical language.
  • This article explains Pathophysiology of Insulin Resistance in simple medical language.
  • This article explains Diagnosis of Insulin Resistance in simple medical language.
  • This article explains Treatment of Insulin Resistance in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Severe symptoms, breathing difficulty, fainting, confusion, or rapidly worsening illness.
  • New weakness, severe pain, high fever, or symptoms after a serious injury.
  • Any symptom that feels urgent, unusual, or unsafe for the patient.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.
Definition

Insulin resistance is identified as an impaired biologic response to insulin stimulation of target tissues, primarily the liver, muscle, and adipose tissue. Insulin resistance impairs glucose disposal, resulting in a compensatory increase in beta-cell insulin production and hyperinsulinemia. The metabolic consequences of insulin resistance can result in hyperglycemia, hypertension, dyslipidemia, visceral adiposity, hyperuricemia, elevated inflammatory markers, endothelial dysfunction, and a prothrombic state. Progression of insulin resistance can lead to metabolic syndrome, nonalcoholic fatty liver disease (NAFLD), and type 2 diabetes mellitus.

Causes of Insulin Resistance

Insulin resistance etiology can be divided into acquired, hereditary, and mixed. The great majority of people with insulin resistance fall into the acquired categories.

Acquired

  • Excess dysfunctional adipose tissue
  • Aging
  • Physical inactivity
  • Nutritional imbalance
  • Medications (glucocorticoids, anti-adrenergic, protease inhibitors, atypical antipsychotics, and some exogenous insulin)
  • Increased sodium diets
  • Glucose toxicity
  • Lipotoxicity from excess circulating free fatty acids

In addition to the heritable components of the above etiologies of insulin resistance, there are a number of unrelated genetic syndromes with associated insulin resistance.

Genetic

  • Myotonic Dystrophy
  • Ataxia-telangiectasia
  • Alstom syndrome
  • Rabson-Mendenhall syndrome
  • Werner syndrome
  • Lipodystrophy
  • PCOS
  • Type-A insulin resistance: Characterized by severe insulin resistance (abnormal glucose homeostasis, ovarian virialization, and acanthosis nigricans) in the absence of anti-insulin antibodies; typically occurs before middle age
  • Type-B insulin resistance: Characterized by the development of anti-insulin antibodies (typically in middle age) with resultant abnormal glucose homeostasis, ovarian hyperandrogenism, and acanthosis nigricans

Of note, an alternative classification of insulin resistance is the division for the site of dysfunction concerning the insulin receptor itself as opposed to etiology. The categories include the following:

  • Pre-receptor
  • Receptor
  • Post-receptor

Pathophysiology of Insulin Resistance

The three primary sites of insulin resistance are the muscle, liver, and adipose tissue. Insulin resistance is postulated to begin in muscle tissue with immune-mediated inflammatory change and excess free fatty acids, causing ectopic lipid deposition. Muscle accounts for up to 70% of glucose disposal. With impaired muscle uptake, excess glucose returns to the liver increasing de novo lipogenesis (DNL) and circulating free fatty acids, further contributing to ectopic fat deposition and insulin resistance

Adipose Tissue

By use of the hyperinsulinemic-euglycemic clamp technique, researchers determined that lipolysis is most sensitive to insulin. Failure of insulin to suppress lipolysis in insulin-resistant adipose tissue, especially visceral adipose tissue, increases circulating free fatty acids. Higher levels of circulating FFAs directly affect both liver and muscle metabolism, further exacerbating insulin resistance.

Muscle Tissue

After intake of a caloric load and conversion to glucose, muscle is the primary site for glucose disposal, accounting for up to 70% of tissue glucose uptake. With excess calorie loads, glucose uptake by muscle exceeds capacity, and excess glucose returns to the liver where it triggers DNL. Increased DNL increases triglyceride and FFA production, causing ectopic fat deposition into the liver, muscle, and adipose tissue. As a result, insulin resistance increases as well as the production of inflammatory markers. Additional factors influencing insulin resistance in muscle tissue include physical inactivity and genetic risk.

Hepatic Tissue

Insulin resistance in muscle results in increased delivery of glucose substrate to the liver, which triggers DNL, with associated infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation, and ectopic lipid deposition. Insulin resistance in adipose tissue results in increased lipolysis in adipocytes, resulting in increased circulating FFA and further exacerbating steatosis and insulin resistance in muscle tissue. In the presence of caloric intake, insulin reduces hepatic glucose production via inhibition of glycogenolysis, limiting the postprandial rise in glucose. With insulin resistance, this feedback mechanism is impaired, and hepatic glucose production continues to rise, even as postprandial glucose rises. Glucotoxicity, associated with elevated glucose levels, further contributes to insulin resistance.

Diagnosis of Insulin Resistance

The clinical presentation of insulin resistance is variable with respect to both history and physical exam findings. It is dependent on the subset of insulin resistance present, duration of the condition, level of beta-cell function, and the individual’s propensity for the secondary illnesses due to insulin resistance. Common presentations include:

  • The asymptomatic patients with obesity, hypertension, or hyperlipidemia
  • Those with metabolic syndrome
  • Prediabetes or type 2 insulin is low or not working well. সহজ বাংলা: রক্তে চিনি বেশি থাকার রোগ।" data-rx-term="diabetes" data-rx-definition="Diabetes is a condition where blood sugar stays too high because insulin is low or not working well. সহজ বাংলা: রক্তে চিনি বেশি থাকার রোগ।">diabetes mellitus
  • Those with symptomatic microvascular disease (retinopathy, pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।" data-rx-term="neuropathy" data-rx-definition="Neuropathy means nerve damage or irritation causing pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।">neuropathy, or nephropathy)
  • Those with macrovascular disease (stroke, PAD, and CAD)
  • Those with PCOS
  • Those with type A or type B insulin resistance
  • Elevated blood pressure
  • Gender and race-specific increased waist circumference
  • Those with xanthelasma or xanthomas
  • The stigmata of PCOS (menstrual irregularities, hirsutism, acne, and alopecia)
  • Acanthosis nigricans, a patchy velvety brown pigmentation around the neck axilla and groin regions.
  • The stigmata of one of several genetic syndromes that include insulin resistance

Multiple criteria for metabolic syndrome exist. In 2009, a joint scientific statement harmonizing criteria for MetS was released. MetS is identified by the presence of 3 or more of the following diagnostic cut points:

  • A waist circumference of 32” to 40” based on gender and race
  • Elevated triglycerides greater than or equal to 150 mg/dL
  • Reduced HDL less than 40 mg/ dL in men, less than 50 mg/ dL in women
  • Elevated blood pressure greater than or equal to 130 mmHg systolic and/or greater than or equal to 85 mmHg diastolic
  • Elevated fasting glucose greater than or equal to 100 mg/ dL

The American College of Endocrinology identify specific physiologic abnormalities which increase the risk of Insulin Resistance Syndrome as follows:

  • Impaired glucose tolerance or impaired fasting glucose
  • Abnormal uric acid metabolism
  • Dyslipidemia (increased triglycerides, decreased HDL-C, or small, dense LDL)
  • Hemodynamic changes such as elevated blood pressure
  • Prothrombic factors (PAI-1, fibrinogen)
  • Markers of inflammation (CRP, WBC, etc.)
  • Endothelial dysfunction

Other factors include the following:

  • Body mass index (BMI) greater than or equal to 25 kg/m2
  • Diagnosis of CVD, PCOS, NAFLD, or acanthosis nigricans
  • A family history of T2DM, hypertension, or CVD
  • Sedentary lifestyle
  • Non-Caucasian ethnicity
  • Age greater than 40 years

Differential Diagnosis

  • Obesity: Excess body weight is categorized as overweight (BMI of 25 to 29.9), class I obesity (BMI of 30 to 34.9), class II obesity (BMI 35.0 to 39.9), and class III obesity (BMI greater than 40)
  • Hypertension: The most recent ACC/AHA guidelines for the diagnosis of hypertension include systolic BP greater than or equal to 130 mmHg or diastolic BP greater than or equal to 80 mmHg
  • Hypertriglyceridemia: Elevated triglyceride levels (greater than or equal to 150 mg/dL)
  • Type 1 diabetes
  • Type 2 diabetes
  • Glucose intolerance including impaired fasting glucose, impaired glucose tolerance, gestational diabetes, type 1 diabetes, and type 2 diabetes
  • Lipodystrophy (acquired, localized or generalized): Loss of adipose tissue that results from either genetic or acquired causation and can result in the ectopic deposition of fat in either hepatic or muscular tissue
  • Polycystic Ovary Syndrome (PCOS)

Treatment of Insulin Resistance

Intensive Lifestyle Intervention

Lifestyle intervention represents the cornerstone of treatment for insulin resistance. Dietary intervention should include a combination of calorie restriction and reduction of high glycemic index carbohydrates. Physical activity improves both calorie expenditure and insulin sensitivity in muscle tissue.

Individuals with insulin resistance are at high risk of developing T2DM. The Diabetes Prevention Program and its Outcomes Study (DPP & DPPOS) demonstrated that lifestyle intervention was both a significant and cost-effective intervention for diabetes prevention in high-risk adults.

  • A dietary therapy with sodium reduction, fat reduction, calorie restriction, and attention to the glycemic index of foods
  • Education, support, and personalized programs
  • A 7% weight loss reduced the onset of T2DM by 58%
  • DPP included a metformin arm which reduced the onset of T2DM by 31%

Specific Pharmacological Interventions for Blood Glucose Management

While no medications are FDA approved for the treatment of insulin resistance, general approaches include the following:

  • Metformin: This is considered first-line therapy for medication treatment of T2DM and is approved for use in polycystic ovary syndrome. The DPP/DPPO study showed that the addition of metformin and lifestyle interventions combined were medically useful and cost-effective. Despite the concerns of use in mild to moderate renal dysfunction, several organizations including the American Geriatric Society and the KDIGO (Kidney Disease Improving Global Outcomes) guidelines endorse use as long as the GFR is greater than 30.
  • Glucagon-like peptide one inhibitors: The GLP-1 receptor agonists stimulate the GLP-1 receptors in the pancreas, thereby increasing insulin release and inhibiting glucagon secretion. Use of GLP-1 agonists is associated with weight loss, which may reduce IR. Liraglutide is FDA approved as and an anti-obesity agent.
  • Sodium-glucose cotransporter two inhibitors: The SGLT2 inhibitors increase the excretion of urinary glucose, thereby reducing plasma glucose levels and exogenous insulin requirements. Use of SGLT2 inhibitors has also been associated with weight loss, which may reduce insulin resistance.
  • Thiazolidinediones: TZDs improve insulin sensitivity by increasing insulin-dependent glucose disposal in muscle and adipose tissue as well as decreasing hepatic glucose output. Though effective, associated secondary weight gain and fluid retention, with associated cardiovascular concerns, limit their use.
  • Dipeptidyl peptidase-4 inhibitors: The DPP-4 inhibitors prolong the activity of endogenous GLP-1 and gastric inhibitory polypeptide(GIP) by preventing their breakdown.

For individuals on insulin therapy:

  • The use of concentrated insulin preparations when large doses (greater than 200 units per day) of insulin are required to improve tolerance and absorption. At this time U-500 and U-200 Lispro and U-300 Glargine

Surgery

Surgical intervention in the form of gastric sleeve, banding, and bypass is available for qualified individuals with obesity. The excess fat loss associated with bariatric surgery improves insulin sensitivity. The STAMPEDE trial has shown good evidence of the benefit of bariatric surgery on type 2 diabetes.

Effect of Exercise in Diabetes and Insulin Resistance

Short-Term Effects of Exercise

Type 2 Diabetes – Exercise leads to an increase in insulin sensitivity. Patients on oral hypoglycemic have decreased blood glucose concentration after exercise. Studies have suggested that patients who were fasting, no change in blood glucose concentrations noted; whereas, blood concentrations decreased in patients who exercised after eating.

Type 1 Diabetes

  • Patients with well-controlled diabetes on insulin regimen: Higher serum insulin concertation is noted during exercise due to increased temperature and blood flow leading to increased absorption from subcutaneous depots. Exogenous insulin can’t be shut off. Hence, these patients have a drop in blood glucose levels much larger than in normal individuals.
  • Patients with diabetes and poor metabolic control: Exercise causes a paradoxical elevation in blood glucose concentrations

Long-Term Effects of Exercise

Patients are insulin resistant due to many defects in glucose metabolism.

  • Decreased number and function of both insulin receptors and glucose transporters
  • Decreased activity of some intracellular enzymes
  • Low maximal oxygen uptake during exercise

An exercise program leads to increased activity of mitochondrial enzymes, increased insulin sensitivity, and muscle capillary recruitment. Adding resistance training to aerobic exercise provides an additional benefit of increased insulin sensitivity.

Blood Glucose Management During Exercise

General principles for diabetic patients for exercise regimens:

  • Maintain a high level of fluid intake before, during, and after exercise
  • Maintaining blood sugar logs before, during, and after exercise
  • If blood glucose is less than 100 mg/dL, it is recommended to ingest food, such as glucose tablets, juice. About 15 to 30 grams of quickly absorbed carbohydrate is recommended to be ingested 15 to 30 minutes before exercise. Extra ingestion of food may be warranted during exercise based on blood glucose testing during the exercise.  Immediately after excise slowly absorbed carbohydrates such as dried fruit, granola bars or trail mix are recommended as patients are at risk of late hypoglycemia.
  • Vigorous exercise is to be avoided in the presence of substantial hyperglycemia greater than 250 mg/dl.
  • Hypoglycemia is not common in patients with type 2 diabetes not treated with insulin or oral hypoglycemics. Ingestion of extra carbohydrates is not required.
  • Use insulin about 60 to 90 minutes before exercise to prevent increased insulin absorption along with injecting in a site other than muscle to be exercised. For example, inject into arms when cycling exercise and into the abdomen when the exercise involves both the arms and legs.

Blood Glucose Determination

To determine if the patient has developed type 2 diabetes the patient needs to have the following outcomes on these tests:

  • A fasting plasma glucose level of 126 mg/dL or higher.
  • A 2-hour plasma glucose level of 200 mg/dL or higher during a 75-g oral glucose tolerance test (OGTT).
  • Random plasma glucose of 200 mg/dL or higher in the presence of symptoms of hyperglycemia.
  • A hemoglobin A1c level of 6.5% or higher.

Prevention of complications

To prevent complications of hyperglycemia, the following preventive approaches are recommended:

  • Refer to an ophthalmologist for yearly eye exams.
  • Monitor A1c levels every 3-6 months.
  • Check urinary albumin levels every 12 months.
  • Examine the feet at each clinic visit.
  • Maintain the Blood pressure to less than 130/80 mmHg.
  • Initiate statin therapy if the patient has hyperlipidemia.
  • Kidney and eye disease by regulation of blood pressure and lowering hyperglycemia.
  • Ischemic heart disease, stroke and peripheral vascular disease by control of hypertension, hyperlipidemia, and cessation of smoking.

Complications

Complications of untreated or uncontrolled hyperglycemia over a prolonged period of time include:

Microvascular complications

Macrovascular complications

  • Coronary artery disease
  • Cerebrovascular disease
  • Peripheral vascular disease

References

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Drink safe fluids and monitor temperature.
  • In dengue-prone areas, discuss CBC and platelet count when fever persists or warning signs appear.
  • Use tepid sponging for high fever discomfort; avoid ice-cold bathing.

OTC medicine safety

  • For fever, common fever medicine may be discussed with a clinician or pharmacist.
  • Avoid aspirin/ibuprofen-like medicines in suspected dengue unless a doctor says it is safe.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Fever with breathing difficulty, confusion, repeated vomiting, bleeding, severe weakness, stiff neck, or dehydration needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Doctor / qualified healthcare provider
Tests to discuss with doctor
  • Basic vital signs: temperature, pulse, blood pressure, oxygen level if needed
  • Relevant blood, urine, imaging, or specialist tests only after clinical assessment
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Insulin Resistance – Types, Causes, Symptoms, Treatment

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area from the RX Article Professional Blocks panel.

More from this topic
  1. Benign Familial Nocturnal Alternating Hemiplegia of Childhood (BNAHC)

    DefinitionBenign? familial nocturnal alternating hemiplegia of childhood (BNAHC) is a very rare childhood condition in which a child has repeated night-time attacks of weakness? or paralysis...

    October 21, 2025 • Health (A - Z)
  2. Benign Adult Familial Myoclonic Epilepsy (BAFME

    DefinitionBenign? adult familial myoclonic epilepsy (BAFME) is a rare, inherited brain condition. It usually starts in late teenage years or during adult life. The main signs...

    October 20, 2025 • Health (A - Z)
  3. Polyglandular Autoimmune Syndrome Type 1 (APS-1)

    DefinitionPolyglandular autoimmune? syndrome type 1 (APS-1)—also known as autoimmune? polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)—is a rare, inherited immune-system disease caused by harmful changes in the AIRE gene. Because...

    September 30, 2025 • Health (A - Z)
  4. Tripeptidyl-Peptidase II (TPP2) Deficiency

    DefinitionTripeptidyl-Peptidase II (TPP2) deficiency is a rare, inherited condition where the TPP2 gene does not work properly. The TPP2 gene makes an enzyme (tripeptidyl-peptidase II) that...

    September 29, 2025 • Health (A - Z)
  5. Painful Bruising Syndrome

    DefinitionPainful bruising syndrome is a very rare condition where tender, burning or stinging skin patches suddenly appear and then turn into bruises (purpura) within about a...

    September 29, 2025 • Health (A - Z)
  6. Autoerythrocyte Sensitization Syndrome

    DefinitionAutoerythrocyte Sensitization Syndrome is a rare condition where people develop painful, tender skin swellings that turn into dark bruises (ecchymoses) within about a day. The bruises...

    September 29, 2025 • Health (A - Z)
  7. Autism Facial Port Wine Stain Syndrome

    DefinitionAutism-facial port-wine stain syndrome describes a very rare pattern seen in a handful of children: a unilateral facial port-wine stain (a flat, maroon-to-purple birthmark caused by...

    September 29, 2025 • Health (A - Z)
  8. Intellectual Developmental Disorder due to AUTS2 Deficiency

    DefinitionIntellectual developmental disorder due to AUTS2 deficiency is a rare genetic neurodevelopmental condition. It happens when one copy of the AUTS2 gene does not work properly....

    September 29, 2025 • Health (A - Z)
  9. Autism Spectrum Disorder due to AUTS2 Deficiency

    DefinitionAutism spectrum disorder due to AUTS2 deficiency is a rare, genetic neurodevelopmental condition caused by harmful changes (variants) in the AUTS2 gene. The gene helps control...

    September 29, 2025 • Health (A - Z)
  10. Ancylostomiasis (Hookworm Infection)

    DefinitionAncylostomiasis is the medical name for hookworm infection? in humans. Tiny worm larvae living in contaminated soil can enter your body (usually through bare feet). They...

    September 17, 2025 • Health (A - Z)